Prodotti della ricerca

 

UNICA IRIS Institutional Research Information System

IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.

Mostra risultati da 1 a 20 di 310
successivo >
TitoloData di pubblicazioneAutoriTipoAbstract
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' studyIn stampaSCARTOZZI, MARIO  ; CASCINU, STEFANO  ; ZIRANU, PINA  ; 1 Contributo su Rivista::1.1 Articolo in rivista
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials2019SCARTOZZI, MARIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter2019SCARTOZZI, MARIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations2019SCARTOZZI, MARIO  ; MURGIONI, SABINA  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Immunotherapy associated pulmonary toxicity: Biology behind clinical and radiological features2019PORCU, MICHELE  ; SOLINAS, CINZIA  ; SCARTOZZI, MARIO  ; SABA, LUCA  1 Contributo su Rivista::1.1 Articolo in rivista
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: Training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)2019CASADEI GARDINI, ANDREA  ; PUGLIESE, GABRIELE  ; SCARTOZZI, MARIO  ; CASCINU, STEFANO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer2019MADEDDU, CLELIA  ; SCARTOZZI, MARIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials2019CASADEI GARDINI, ANDREA  ; PUZZONI, MARCO  ; CASCINU, STEFANO  ; SCARTOZZI, MARIO  1 Contributo su Rivista::1.1 Articolo in rivista
ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib2019CASCINU, STEFANO  ; SCARTOZZI, MARIO  ; CASADEI GARDINI, ANDREA  1 Contributo su Rivista::1.1 Articolo in rivista
Systemic therapy for the treatment of endometrial cancer2019NERI, MANUELA  ; MELIS, GIAN BENEDETTO  ; PIRAS, BEATRICE  ; VALLERINO, VALERIO  ; PAOLETTI, ANNA MARIA  ; MADEDDU, CLELIA  ; SCARTOZZI, MARIO  ; MAIS, VALERIO  1 Contributo su Rivista::1.1 Articolo in rivista
Clustered protocadherins methylation alterations in cancer2019VEGA BENEDETTI, ANA FLORENCIA  ; BLOIS, SYLVAIN SERGE DANIEL  ; COLUMBANO, AMEDEO  ; RESTIVO, ANGELO  ; ZORCOLO, LUIGI  ; PUZZONI, MARCO  ; SCARTOZZI, MARIO  ; ZIRANU, PINA  ; ENNAS, MARIA GRAZIA  ; ZAVATTARI, PATRIZIA  1 Contributo su Rivista::1.1 Articolo in rivista
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience2019ZAVATTARI, PATRIZIA  ; SCARTOZZI, MARIO  ; CASCINU, STEFANO  ; CASADEI GARDINI, ANDREA  1 Contributo su Rivista::1.1 Articolo in rivista
Radiological evaluation of response to immunotherapy in brain tumors: Where are we now and where are we going?2018PORCU, MICHELE  ; SOLINAS, CINZIA  ; GAROFALO, PAOLO  ; SCARTOZZI, MARIO  ; SABA, LUCA  1 Contributo su Rivista::1.1 Articolo in rivista-
The abscopal effect in the era of cancer immunotherapy: a spontaneous synergism boosting anti-tumor immunity?2018SOLINAS, CINZIA  ; PORCU, MICHELE  ; SABA, LUCA  ; SCARTOZZI, MARIO  1 Contributo su Rivista::1.1 Articolo in rivista
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?2018SCARTOZZI, MARIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-62018MADEDDU, CLELIA  ; SCARTOZZI, MARIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista-
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma2018SCARTOZZI, MARIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
BRAF-mutant colorectal cancer, a different breed evolving2018LAI, ELEONORA VERONICA  ; MARIANI, STEFANO  ; PUSCEDDU, VALERIA  ; CONI, PIERPAOLO  ; FANNI, DANIELA  ; PUZZONI, MARCO  ; ZIRANU, PINA  ; FAA, GAVINO  ; SCARTOZZI, MARIO  1 Contributo su Rivista::1.1 Articolo in rivista
The PANDA study: A randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients2018SCARTOZZI, MARIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial2018SOBRERO, ALBERTO  ; SCARTOZZI, MARIO  ; 1 Contributo su Rivista::1.1 Articolo in rivista
   
credits unica.it | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar